Edinburgh, United Kingdom

Charalampos Ioannidis

This inventor holds 1 USPTO granted patent. Top assignee: The University of Edinburgh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charalampos Ioannidis. Retrieved from https://idiyas.com/inventor/charalampos-ioannidis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charalampos Ioannidis: Innovator in Cyclophilin Modulation

Introduction

Charalampos Ioannidis is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of cyclophilins. His work focuses on developing compounds that can serve as inhibitors of cyclophilins and modulators of cyclophilin-like proteins.

Latest Patents

Ioannidis holds a patent for "Compounds for the modulation of cyclophilins function." This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, which are useful as inhibitors of cyclophilins. The patent also discusses the applications of these compounds in treating various disorders. The detailed formula includes various groups and substituents that enhance the efficacy of the compounds.

Career Highlights

Charalampos Ioannidis is affiliated with the University of Edinburgh, where he conducts his research and development activities. His work has led to advancements in understanding the role of cyclophilins in various biological processes. He has been recognized for his innovative approach to drug development.

Collaborations

Some of his notable coworkers include Malcolm Walkinshaw and Alessio De Simone. Their collaborative efforts have contributed to the success of his research projects and patent applications.

Conclusion

Charalampos Ioannidis is a prominent figure in the field of pharmaceutical innovation, with a focus on cyclophilin modulation. His contributions are paving the way for new therapeutic options in treating various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…